France has approved an official medical cannabis trial and the search is now underway for patients that wish to take part in the experiment.
The French Agency for Drug Safety (ANSM) compiled an expert committee to assess the potential therapeutic benefits of marijuana in December 2018. The 13-strong panel has been deliberating ever since, while leading Canadian companies including Aurora Cannabis have made the case for legalization.
The committee has now decided to authorize a clinical trial featuring French patients suffering from pain that is not yet treated by other medicines. It is looking for anyone in palliative care, epilepsy patients and anyone suffering from the side effects of chemotherapy, while patients experiencing muscle spasms related to multiple sclerosis are also invited to take part.
It represents another step in the right direction for cannabis advocates in France, but anyone hoping to see a regulated medical marijuana industry spring up
... read more at: https://grizzle.com/france-detailed-cannabis-trial/